Technical aspects, current indications, and results of chimney grafts for juxtarenal aortic aneurysms  by Coscas, Raphael et al.
Technical aspects, current indications, and results
of chimney grafts for juxtarenal aortic aneurysms
Raphael Coscas, MD,a Hicham Kobeiter, MD,b Pascal Desgranges, MD, PhD,a and
Jean-Pierre Becquemin, MD,a Créteil, France
Introduction: Juxtarenal aortic aneurysms (JAA) can be successfully treated by fenestrated/branched endografts (FBE),
but with significant cost and a long manufacturing process. “Chimney” grafts (CG) have been advocated as a cheaper and
immediately available alternative. Because scant data are available, the aim of this study was to report our early experience
with CG to treat JAA.
Methods: From 2000 to 2010, data were prospectively collected for 975 consecutive endovascular aortic repairs (EVAR).
Among them, 57 patients undergoing EVAR for JAA were retrospectively reviewed, and those undergoing planned CG
were analyzed further. All CG patients were thought to be at high risk for open surgery and were usually unsuitable for
FBE.
Results: The series included 16 patients with CGs for JAA, and 14 (88%) were men. Median age was 73 years old (range,
22-91 years). Median aneurysm diameter was 62 mm (range, 30-100 mm). Indications for CG were an anatomic
condition precluding FBE in four patients (including three with iliac occlusion), emergent repair of painful or ruptured
aneurysm in four, a large-diameter aneurysm whose treatment could not wait for the manufacturing delay of an FBE in
three, type Ia endoleak in three patients previously treated by infrarenal EVAR, and elective in two. Treatment involved
26 target vessels (6 superior mesenteric arteries, 20 renal arteries). Intraoperative technical success was 94% (1 type Ia
endoleak). Postoperatively, one patient died of a retroperitoneal hemorrhage and one patient died of mesenteric ischemia
after leaving the hospital against medical advice. One patient had a stroke, and four presented with local vascular
complications (iliac dissection, hematoma). The postoperative computed tomography scan showed two patients (12.5%)
had a type Ia endoleak. With a median follow-up of 10.5 months (range, 2-19 months), two more patients died (not
aneurysm-related). No rupture occurred. All target vessels were patent (primary patency rate, 96%), and one type Ia
endoleak persisted.
Conclusion: CG is feasible and efficient to treat JAA in patients unsuitable for FBE. However, in this preliminary
experience, complications of devices insertion and type I endoleaks were not rare. Until the anatomic applicability of FBE
is extended and off-the-shelf FBE devices are available, CG remains a feasible endovascular option for high-risk JAA
patients. ( J Vasc Surg 2011;53:1520-7.)
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pEndovascular aortic repair (EVAR) is a widely used
technique for the treatment of infrarenal aortic aneu-
rysms1-4; however, management of juxtarenal aortic aneu-
rysms (JAA) remains controversial. Until recently, treat-
ment of JAA was open repair.5-7 Fenestrated and branched
endografts (FBE) have been recently developed as an alter-
native to open surgery, with promising early-term and
medium-term results.8-10 However, strict anatomic re-
quirements, high costs, and long manufacturing delays
limit the applicability of the technique.
“Chimney” grafts (CG) have been advocated as a pos-
sible endovascular option for aortic aneurysms involving
critical side branches,11,12 such as renal and superior mes-
enteric arteries. The CG involves concurrent deployment of
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1520standard aortic endograft associated with covered stents
n the target arteries, and thus it has the advantage of being
mmediately available and may be cheaper than FBE. Be-
ause data are limited to short reports in the setting of
AA,11,13-15 the aim of this study was to report our prelim-
nary experience with CG for JAA in an effort to review its
ndications in the era of FBE.
ETHODS
Study population. From January 2000 to June 2010,
ata for 975 consecutive EVARs performed at our institu-
ion were prospectively collected in a database. Apart from
atients included in the Anévrysme de l’aorte abdominale,
hirurgie versus Endoprothèse (ACE) trial,16 all patients
ere considered at high risk for open surgery by physio-
ogic and anatomic characteristics. Among them, 57
VARs for JAA were retrospectively reviewed, comprising
9 patients with fenestrated endografts, 2 with branched
ndografts, and 16 with CG. This last subset of patients was
elected and their data were analyzed further. Excluded
rom analysis were patients who required renal artery stent-
ng to rescue an accidental coverage during an EVAR
rocedure.
Preoperative management. An injected computed
omography (CT) scan of the entire aorta was performed
t
d
o
o
s
f
d
a
r
e
s
“
t
o
s
9
fl
k
u
p
v
r
F
p
p
p
i
a
c
a
t
(
d
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 6 Coscas et al 1521before the intervention. The scans were examined using
3-dimensional reconstruction Advantage imaging workstations
(GE Medical Systems, Milwaukee, Wisc) or AquariusNET/
Intuition software (TeraRecon Inc, San Mateo, Calif). To
be amenable to a CG, patients had to present a satisfactory
proximal landing zone of healthy aorta 15 mm in length
between the celiac trunk and the renal arteries level. During
the study period, CG was usually reserved for patients
considered unfit for both open surgery and FBE.
Technical aspects. All procedures were performed in
the presence of at least an interventional radiologist (H.K.)
and a senior vascular surgeon (J.P.B., P.D.) in an operating
room or an angiography suite. General anesthesia was
induced, the patient was placed supine, and both arms and
groins were prepared. When one target artery was involved
in the repair, the left brachial artery was surgically exposed
through an incision at the internal side of the arm. When
two target arteries were involved, both brachial arteries
were exposed in a similar fashion. When the repair consisted
in a bifurcated aortic endograft, both femoral arteries were
exposed in the groin through short transversal incisions.
When a tubular graft was planned, one femoral artery was
surgically dissected, and the other one was punctured, if
necessary, to perform angiographic controls.
At the beginning of the procedure, 0.5 mg/kg of
unfractionated heparin was administered intravenously.
For each target vessel involved, one brachial artery was
punctured and a 7F to 10F introducer (Cook Flexor, 90
cm; Cook Medical, Bloomington, Ind) was pushed down
to the distal descending aorta. The target artery was usually
catheterized using a 0.035-inch 260-cm-long hydrophilic
guidewire (Terumo Europe, Leuven, Belgium) over a
headhunter (Terumo), a vertebral (Terumo), or a JB1
(Cook Medical) angiography catheter. The catheter was
then introduced as far as possible into the target artery.
The 0.035-inch wire was exchanged for a stiffer Rosen
guidewire (Cook Medical). After this, the long introducer
was pushed 2 to 3 cm into the renal artery, and a small-
vessel covered stent was positioned into the introducer at
this level but was not deployed immediately. Two different
types of covered stent were used at the discretion of the
procedural team, depending on the target artery anatomy
(angulation, calcification, stenosis). A Fluency (40-mm
long, Bard, Tempe, Ariz) self-expandable covered stent was
used in combination with 9F or 10F long introducers
(Cook Flexor 90 cm, Cook Medical), whereas in several
cases, we instead used 38-mm-long Advanta-V12 (Atrium
Europe, Manchester, UK) balloon-expandable covered
stents combined with 7F introducers (Cook Flexor 90 cm,
Cook Medical).
The stent diameters ranged 5 to 7 mm for renal arteries
and 7 to 9 mm for the superior mesenteric artery (SMA).
The definite stent size was chosen according to measure-
ments made using the reconstruction software. These cov-
ered stents were partly positioned in the aorta in a manner
such that their proximal extremity was positioned 2 to 3
mm above the intended level of the first proximal covered
stent of the aortic endograft. After this, the main body of phe Zenith aortic endograft (Cook Medical) was intro-
uced, positioned, and deployed at the level of the previ-
usly determined sealing zone, thereby covering the ostia
f the target vessels involved. The small-vessel covered
tents were then deployed after pulling out the introducer a
ew centimeters from the artery.
Finally, endograft limbs and possible extensions were
eployed, and completion angiography (anteroposterior
nd lateral views) was performed to assess the patency of the
epair and detect possible endoleaks. In case of type I
ndoleak, the aortic endograft and the small-vessel covered
tents were ballooned simultaneously using a proximal
kissing balloon” technique (Fig 1). When renal stents or
he aortic endograft were positioned at the level of the SMA
stium and partially covered it, SMA stenting using a
elf-expandable uncovered stent was performed with a
-mm uncovered Absolut stent (Abbott) to preserve blood
ow to the intestine (Fig 2). In case of small-vessel stent
inking, and routinely for the last patients of the series, an
ncovered self-expandable stent was deployed into the
reviously inserted balloon-expandable stent, and vice
ersa, with the goal to improve long-term patency of the
epair.
Postoperative management. After the procedure, all
ig 1. The proximal “kissing balloon” technique used after de-
loyment of a chimney graft (CG) is shown. In this patient, a
ersistent type Ia endoleak was noted on the lateral side of the
roximal neck on completion angiography after a CG incorporat-
ng the two renal arteries. A compliant balloon was inflated in the
orta at the level of the left renal stent, which was preserved by the
oncurrent inflation of a noncompliant balloon in the lumen (black
rrows). The right renal stent had been implanted slightly higher
han the left one and ballooning was not necessary at this level
white arrow). This maneuver was successful, and the endoleak
isappeared.atients underwent surveillance for at least 24 hours in the
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June 20111522 Coscas et alFig 2. A patient presented with a descending thoracic aneurysm and a 57-mm juxtarenal aneurysm, with contraindi-
cations to open surgery. A thoracic stent graft was successfully implanted during a first procedure (A), but introduction
of the device through the left iliac axis caused a dissection at this level, rescued by a femorofemoral crossover bypass.
Due to the left iliac thrombosis, a chimney graft (CG) associating an aorto-uni-iliac endograft with stents in the renal
arteries and the superior mesenteric artery (SMA) was implanted to treat the juxtarenal aortic aneurysm (JAA) with a
good result (B-D). Eleven months later, the two aneurysms remained excluded and stable in diameter.Table I. Summary of the 16 patients with juxtarenal aortic aneurysms treated using a chimney graft
Pt Sex Age (years) Indication for CG Vessels involved
Postoperative course (30 days)
Complication Reintervention
1 M 70 Iliac occlusion LRA No No
2 M 69 Iliac dissection LRA, RRA, SMA No No
3 M 69 Iliac occlusion LRA, RRA, SMA RP hematoma Laparotomy
4 M 91 Large aneurysm LRA Iliac dissection Iliac stenting
5 M 78 Proximal failure of a prior infrarenal
endograft
LRA, RRA Iliac dissection, left renal
infarction
No
6 M 80 Painful aneurysm LRA, RRA Seizure No
7 M 76 Low implantation of LRA LRA No No
8 M 22 Ruptured pseudoaneurysm SMA Periscope LRA thrombosis Thrombolysis
9 F 78 Large aneurysm RRA, SMA Death (RP hematoma) Laparotomy
10 F 78 Proximal failure of a prior infrarenal
endograft
LRA, RRA RP hematoma, right CVA,
right renal infarction
No
11 M 69 Proximal failure of a prior infrarenal
endograft
LRA, RRA No No
12 M 59 Ruptured pseudoaneurysm SMA No No
13 M Ruptured pseudoaneurysm SMA Death (intestinal ischemia) Laparotomy
14 M 62 Large aneurysm LRA, RRA No No
15 M 70 Elective LRA No No
16 M 83 Elective RRA No NoCRI, Chronic renal insufficiency; CRF, chronic renal failure; CVA, cerebrovascular accident; F, female; LRA, left renal artery; M, male; RP, retroperitoneal;
RRA, right renal artery; SMA, superior mesenteric artery.
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Volume 53, Number 6 Coscas et al 1523recovery room. An oral antiplatelet agent, either daily aspi-
rin (75-250 mg) or clopidogrel (75 mg), and statin therapy
were administered to all patients before the procedure and
continued lifelong. In the absence of specific contraindica-
tions (renal failure), contrast-enhanced CT scans of the
entire aorta were performed before discharge, at 6 and 12
months, and planned yearly thereafter to assess stent graft
behavior (patency, sealing, migration).
RESULTS
Demographics. Demographics of the study popula-
tion are reported in Table I. During the study period, 16
consecutive patients underwent JAA treatment using a CG.
The median age at intervention was 73 years (range, 22-91
years), and 14 patients (88%) were men. Median aneurysm
diameter was 62 mm (range, 30-100 mm). Indication to
use of a CG in these patients was emergent repair of a
painful or ruptured aneurysm in four, large diameter JAA
(70 mm) whose treatment could not wait for the manu-
facturing delay of an FBE in three, migration of a previously
inserted aortic endograft resulting in a type Ia endoleak in
three, occlusion/dissection of an iliac artery in three, low
implantation of a renal artery in one, and elective in two,
who were the last two patients in the series.
The main cardiovascular risk factors were hypertension
in 11 patients (69%), dyslipidemia in 9 (56%), tobacco use
in 6 (38%), obesity (body mass index 30 kg/m2) in 5
(31%), and diabetes in 2 (13%). Two (13%) patients had
preoperative nondialyzed chronic renal insufficiency, and
two patients (13%) had undergone kidney transplantation
(patients 12 and 13, Table I). Five patients (31%) had a
history of aortic surgery, including four EVAR (three infra-
renal and one descending thoracic endografts) and one
Table I. Continued
Postoperative course (30 days)
Follow-up (months)Endoleak Renal function
No Unchanged 19
No Unchanged 17
No Unchanged 17
No Unchanged 15
Type Ia Unchanged 5
No Unchanged 2
Unknown origin Unchanged 14
No 42 mL/min 13
No . . . . . .
Type Ia 16 mL/min 11
No Unchanged 10
No Unchanged 9
No Unchanged . . .
No Unchanged 7
No Unchanged 7
No Unchanged 4uprarenal aortic suture after penetrating aortic injury. Dis-
ase was classified in accordance with the American Society
f Anesthesiologists (ASA) classification: 2 patients were
SA 2, 11 were ASA 3, and 2 were ASA 4.
Intraoperative management. Median operative time
as 150 minutes (range, 120-360 minutes) and median
uoroscopy time was 30 minutes (range, 15-150). A me-
ian amount of 150 mL of contrast was used (range,
0-250 mL). Blood loss was minimal in all cases. All aortic
epairs were performed using a Cook device (Bloomington,
nd) and consisted of a Zenith bifurcated endograft in
even patients (44%), an aorto-uni-iliac endograft associ-
ted with a femorofemoral crossover bypass in five (31%),
nd a proximal tubular aortic extension in four (25%). A
otal of 26 target vessels were involved (1 in 8 patients, 2 in
patients, and 3 in 2 patients), comprising 20 renal arteries
nd 6 superior mesenteric arteries. Costs of stents and
ndografts used are reported in Table II.
After complete deployment of the CG, the intraopera-
ive angiogram showed four patients had a type Ia endoleak.
hey were all immediately treated using the proximal “kissing
alloon” technique. One patient with persistent type Ia en-
oleak required proximal coil embolization, resulting in
artial resolution of the leak. No other patients were found
o have an endoleak on the final completion angiogram;
herefore, intraoperative technical success was obtained in
5 patients (94%).
Postoperative mortality. One patient died of hemor-
hagic shock 10 hours after the intervention. Resuscitation
aneuvers and emergent open surgical conversion were
nsuccessful. Intraoperatively, a retroperitoneal hemor-
hage was found on the left side of the aorta, but the
leeding origin could not be clearly identified. Another
Status Endoleak
e and healthy No
e and CRF No
e and healthy No
e and healthy No
th (pulmonary embolism) —
th (seizure) —
e and healthy Unknown origin
e and CRF No
— —
e, left upper limb weakness, stage III CRI
FR 32 ml/min)
Type Ia
e and healthy No
e and healthy No
. . . —
e and healthy No
e and healthy No
e and healthy NoAliv
Aliv
Aliv
Aliv
Dea
Dea
Aliv
Aliv
Aliv
(G
Aliv
Aliv
Aliv
Aliv
Aliv
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June 20111524 Coscas et alpatient left the hospital against medical advice on postop-
erative (POD) 3 after the procedure, without any oral
antiplatelet or statin therapy and before postoperative CT
scan. He was readmitted at POD 22 for mesenteric isch-
emia caused by mesenteric stent thrombosis. Despite an
emergent laparotomy, he died postoperatively of multiple
organ failure. Therefore, the 30-day mortality was 12.5% (2
of 16 patients).
Postoperative complications and reinterventions.
Three (18.8%) major complications were noted. One pa-
tient presented with a major immediate postoperative isch-
emic stroke (Rankin score, 5) with left hemiplegia. Apart
from the patient who died of hemorrhagic shock, the major
vascular complications were postoperative retroperitoneal
hematomas, which were documented in two patients sec-
ondary to lumbar and renal branch perforations, respec-
tively. The first patient underwent surgical conversion for
bleeding control and the second was treated with an addi-
tional covered renal stent. Four (25%) minor complications
were documented on the postoperative CT scans: iliac
dissection in two patients, one of which underwent angio-
plasty and stenting of the iliac axis at POD 7, and segmental
renal infarction in two patients.
Endoleaks. The postoperative CT scan documented
type Ia endoleak in two patients. They were considered
minor and no reintervention was performed.
Follow-up. Patients were discharged 8 days (range,
3-30 days) after the intervention. No rupture occurred
during a median follow-up of 10.5 months (range, 2-19
months). All aneurysms were stable or decreased in diam-
eter. Two deaths occurred unrelated to the aorta, consist-
ing of a seizure at 2 months and pulmonary embolism at 5
months; thus, 12 of 16 patients were alive at 6 months for
a survival rate of 75%. Among the 12 patients who were
alive at the last follow-up, chronic renal failure with patent
renal stents had developed in two patients, and one pre-
sented with stage 3 chronic renal insufficiency (Table I).
The nine remaining patients were alive and healthy, and all
target vessels were patent. Primary and secondary patency
rate was 96% (25 of 26 target vessels). One type Ia endoleak
persisted in the patient who had proximal coil emboliza-
tion, and an endoleak of unknown origin developed in one
patient, without aneurysm growth. Therefore, medium-
Table II. Comparison of the costs of grafts used to perfor
with two stented target vessels
Technique Types of grafts used
Chimney graft Zenith (Cook) aortic endograft – main b
Zenith (Cook) aortic endograft – iliac le
Advanta V12 (Atrium) balloon-expandab
Absolut (Abbott) uncovered self-expand
Total
Fenestrated endograft Zenith (Cook) fenestrated endograft
Zenith (Cook) aortic endograft – iliac le
Advanta V12 (Atrium) balloon-expandab
Totalterm clinical success rate was 81% (13 of 16 patients). dISCUSSION
This study shows that CG is technically feasible and
rovides acceptable results in patients with challenging JAA
ho are unsuitable for FBE. Although EVAR has reached a
ertain form of maturity for the treatment of infrarenal
neurysms with sufficient neck lengths,1-4 the use of endo-
ascular means to treat JAA remains debatable. Recent
mprovements of FBE have demonstrated promising re-
ults,8-10 but the use of such devices mandates highly
recise planning, a manufacturing delay of 6 to 12 weeks,
nd an important cost because the devices are customized
or each patient’s anatomy. Moreover, in France, as in
thers countries, FBE for the treatment of JAA are not
ommercially available yet. Therefore, FBE use is limited to
ew investigational centers, and most departments cannot
reat JAA endovascularly.
First described in 2003 by Greenberg et al12 in the
etting of patients with challenging proximal neck, CG has
een recently advocated as a valid option for JAA.11 Be-
ause CG uses standard endovascular materials, it repre-
ents an immediately available option and a cheaper proce-
ure than FBE. In France, the cost of an FBE with two
enestrations for the renal arteries and one scallop for the
MA is €18,551.87 (tax excluded), whereas grafts im-
lanted for a two-vessels chimney technique cost €8230.64
tax excluded) in the setting of JAA (Table II). Despite
hese advantages, current data for the CG technique are
imited to few successful case reports and small series.11-15
or theses reasons, this study had the goal to review the
ndications and results of CG for JAA in the era of FBE.
In our practice, 14 of the 16 JAA patients who under-
ent CG were unsuitable for FBE. These patients could be
eparated into two main subgroups. The first comprised
ight patients whose aneurysm was felt menacing and could
ot wait for the manufacturing delay of FBE: four patients
ad a ruptured or painful aneurysms, three had large-
iameter aneurysms (70 mm), and one patient presented
ith proximal migration of a prior infrarenal Zenith en-
ograft (Cook) with a major type Ia endoleak and a
00-mm aneurysm. The second group included six patients
ho had anatomic contraindications to FBE: three iliac
ssues, two proximal migrations of prior infrarenal en-
two-vessel chimney technique and a fenestrated endograft
Cost (€) No. used per procedure Total (€)
3390.52 1 3390.52
1068.25 2 2136.50
vered stent 741.81 2 1483.62
tent 610.00 2 1220.00
8230.64
16,000.00 1 16,000.00
1068.25 1 1068.25
vered stent 741.81 2 1483.62
18,551.87m a
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Although this study shows the feasibility of CG in these
subgroups of patients, we still think that FBE remains the
endovascular treatment of choice for JAA patients, espe-
cially due to the good short-term and medium-term results
reported with FBE.8-10 However, CG might be a valuable
option for elective JAA cases with one renal artery involved,
as illustrated by the last two patients of the series.
It could be advocated that CG represents an easier
technical option than FBE because catheterization of the
target vessels is direct with CG, whereas the collateral vessel
is accessed through a fenestration or a branch with FBE.
Our results indicate that CG remains a technical challenge.
Procedure durations and fluoroscopy times were reason-
able, but the approach is complex, as demonstrated by
several complications observed during and after the proce-
dure. Our patient who sustained a stroke immediately after
CG highlights the potential difficulties of arch navigation
through the brachial arteries to access target vessels, espe-
Fig 3. Treatment algorithm of juxtarenal aortic aneurys
FBE, fenestrated/branched endograft.cially in cases of bilateral renal involvement mandating the ase of the right brachial artery. The five local vascular
omplications observed, consisting of two iliac dissections
nd three retroperitoneal hematomas, one of them leading
o death, illustrate the long and laborious catheterization of
he renal arteries and the iliac vessels in the setting of
ifficult JAA cases. These local complications are concern-
ng, but because these patients were unsuitable for FBE,
everal complications are likely to be related to the anatomy
f patients who undergo CG in our center rather than the
echnique itself.
Complications observed in this series raise the question
f whether open surgery would have been a better option in
uch cases. Satisfactory results of open repair for JAA have
een reported as being comparable to those of infrarenal
neurysm repair in several series,5,7,17-19 but not in oth-
rs.6,20 Moreover, data are scarce for open JAA repair in the
etting of high-risk patients such as those treated in our
eries. The results of open repair in patients with ruptured
AA,21 JAA with concurrent aortoiliac occlusive disease,
55 mm in our department is shown. CG, Chimney graft;msnd proximal failure after infrarenal EVAR22-25 appear to
t
t
o
t
s
h
h
m
r
l
C
w
v
w
s
(
e
r
i
e
s
a
C
p
r
s
o
pate
JOURNAL OF VASCULAR SURGERY
June 20111526 Coscas et albe inferior to elective repair of uncomplicated JAA cases.
For these reasons, open surgery, FBE, and CG all have a
role in JAA treatment in our current practice. Our treat-
ment algorithm is reported in Fig 3.
The main question with CG is whether proximal seal-
ing of the repair can be safely achieved. One might think
that proximal fixation forces of the graft could be decreased
because of the modifications of the graft–aorta interface,
because covered stents placed between the endograft and
aortic wall decrease the contact surface between the en-
dograft and the aorta. The “gutters”11 located between the
aorta, the stents, and the endograft might also be the origin
of type Ia endoleak. In fact, our results demonstrated 94%
rates of intraoperative technical success (one type Ia en-
doleak) and the absence of aneurysm growth during
follow-up. Finally, two endoleaks (one type Ia and one of
unknown origin) persisted at the last follow-up.
Our sample size is too small to determine which vari-
ables were associated with successful sealing, but the two
patients presenting with type Ia endoleaks on postoperative
CT scans were foreseeably challenging cases. These two
patients were treated for proximal migration of a prior
infrarenal endograft; one was located above a short main
body endograft, and the other presented a 60° angulated
proximal neck. Because no current endovascular material is
adapted to the treatment of type Ia endoleak after CG, we
recommend the use of CG only in patients where a straight
and nondiseased proximal sealing zone can be identified
between the celiac and the renal arteries (Fig 3).
Late patency and stability of CG remains in question.
Fig 4. In contrast to the scheme described by Ohrlande
take a perpendicular path alongside the endograft to en
positioned themselves in a more oblique and helical
(B) posterior views of a two-vessel CG. In the present
covered stents to improve the stability and the long-termOur median follow-up was 10.5 months, but patients rreated for JAA can expect to live much longer. Instinc-
ively, it could be thought that the perpendicular direction
f the stents running along the endograft as described by
he Malmö team11 would cause serious hemodynamic is-
ues. In fact, the final disposition of the stents is more
elical and oblique (Fig 4) and could be compared with the
elical branched endograft design described by others.1,26
Apart from the patient who left the hospital against
edical advice before his control CT scan, all target vessels
emained patent during the follow-up. Therefore, we be-
ieve that the type of side branch perfusion achieved with
G could be in a comparable range than the one observed
ith endografts using fenestrations or branches for target
essels.8-10 Our satisfactory patency rates could be because
e now routinely reinforce balloon-expandable covered
tents with uncovered self-expandable stents and vice versa
Fig 4). The rational for using self-expandable and balloon-
xpandable stents together was to associate satisfactory
esults of balloon-expandable stents in the renal arter-
es27,28 and avoid extrinsic stent compression by the aortic
ndograft using less deformable materials, while allowing a
mooth transition between the balloon-expandable stent
nd the target artery wall using a self-expandable stent.
ONCLUSION
In this retrospective report, we described our first 16
atients undergoing the CG technique for JAA. Present
esults include our learning curve, which probably explains
ome complications directly related to the technical aspects
f the procedure. However, until the publication of CG
11, the stents of a chimney graft (CG) do not necessarily
he renal arteries. Actually, we observed that the stents
ion, as illustrated by these (A) anterior-lateral and
self-expandable stents (arrows) were deployed into the
ncy of the repair.r et al
ter t
direct
case,esults for JAA patients amenable to FBE, we cannot con-
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Volume 53, Number 6 Coscas et al 1527clude that CGs are inferior to FBE. Because our study
demonstrates that aneurysm exclusion can be achieved with
this cheaper and immediately available technique, compar-
ative studies should be undertaken to ensure the superiority
of one technique over the other. Further technical im-
provements might render FBE technology applicable to
patients with challenging anatomy who undergo CG in the
current era, and the development of off-the-shelf FBE
devices for emergent cases could restrain the use of CG in
the future.29 Until such devices are available, CG represents
a feasible option for patients with JAA who have anatomic
contraindications to FBE, JAA mandating emergent treat-
ment, and perhaps patients where one target renal artery is
involved in the repair.
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